This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Biliary tract cancer is a type of cancer that affects the organs and structures of the biliary system, which is responsible for producing and excreting bile. This system is made up of the gallbladder, bile ducts, and the liver. The most common type of biliary tract cancer is cholangiocarcinoma, which begins in the cells of the bile ducts. Other types of biliary tract cancer include gallbladder cancer, ampulla of Vater cancer, and hepatocellular carcinoma (HCC). Risk factors for biliary tract cancer include cirrhosis, chronic inflammation of the bile ducts, primary sclerosing cholangitis, and a genetic predisposition. People with certain inherited conditions, such as familial adenomatous polyposis and Gardner syndrome, may also be at increased risk. Symptoms of biliary tract cancer include jaundice, abdominal pain, weight loss, and fatigue. Other symptoms may include itching, dark-colored urine, and pale stools. Diagnosis is usually made through imaging tests and biopsy. Treatment for biliary tract cancer often involves surgery, radiation therapy, and/or chemotherapy. In some cases, targeted therapy and immunotherapy may be used. The prognosis for biliary tract cancer depends on the stage and location of the cancer, as well as the patient’s overall health. Early detection and treatment can improve the chances of a successful outcome.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States